MAPT and Alzheimer disease: In the field of molecular biomarkers, cerebrospinal fluid (CSF) Aβ42, Aβ42/40 ratio, pTau, and total tau (tTau), named AD core biomarkers, represent the gold standard for AD diagnosis.